Minimal Residual Disease in Acute Myeloid Leukemia: Prognostication and Pitfalls
J Oncol Pract
.
2017 Aug;13(8):485-486.
doi: 10.1200/JOP.2017.025338.
Author
Eytan M Stein
1
Affiliation
1
Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.
PMID:
28796969
DOI:
10.1200/JOP.2017.025338
No abstract available
Publication types
Comment
MeSH terms
Biomarkers, Tumor
Humans
Leukemia, Myeloid, Acute*
Neoplasm, Residual*
Prognosis
Substances
Biomarkers, Tumor